Ocular Therapeutix™ Expands Its Board of Directors with the Election of Industry Leader W. James O’Shea
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today that W. James O’Shea, former President and Chief Operating Officer of Sepracor Inc., has been elected to Ocular’s Board of Directors. “We are very pleased to announce that Jim is joining our Board. With a more than 40-year tenure in the biopharma industry, Jim has ext
